ClinicalTrials.govpublic full text
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
tertiary prevention in colon cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 366566
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.